Assessment of symptoms, quality of life and remnant gastric activity following gastric bypass using Gastric Alimetry® - Wang, Tim Hsu-Han; Varghese, Chris; Calder, Stefan; Gharibans, Armen; Evennett, Nicholas; Beban, Grant; Schamberg, Gabriel; O’Grady, Greg (medRxiv, 2023)
Background While most gastric bypass patients recover well, some experience long-term complications, including nausea, pain, stricture, and dumping. This study aimed to evaluate symptoms and quality of life (QoL) together with remnant stomach function using the novel Gastric Alimetry® system.Method Gastric bypass and conversion-to-bypass patients were recruited. The Gastric Alimetry system (Auckland, NZ) was employed, comprising a high-resolution electrode Array, and validated symptom logging App. The protocol comprised 30-minute fasting baseline, a 218kCal meal stimulus, and 4-hours of post-prandial recordings. Symptoms and QoL were evaluated using validated PAGI questionnaires. Remnant gastric electrophysiology evaluation included frequency, BMI-adjusted amplitude, and Gastric Alimetry Rhythm Index (GA-RI; reflecting pacemaker stability), with comparison to matched controls.Results 38 participants were recruited with mean time from bypass 46.8 ± 28.6 months. One third of patients showed moderate to severe post-prandial symptoms, with patients PAGI-SYM 28 ± 19 vs controls 9 ± 17; PAGI-QoL 37 ± 31 vs 135 ± 22 (p<0.01). Remnant gastric function was markedly degraded shown by undetectable frequencies in 84% (vs 0% in controls), and low GA-RI (0.18 ± 0.08 vs 0.51 ± 0.22 in controls; p<0.0001). Impaired GA-RI and amplitude were correlated with worse PAGI-SYM and PAGI-QOL scores.Conclusion One third of post-bypass patients suffered significant upper GI symptoms with reduced QoL. The bypassed remnant stomach shows highly deranged electrophysiology, reflecting disuse degeneration. These derangements correlated with QoL, although causality was not addressed.Competing Interest StatementSC, AG and GOG are shareholders of Alimetry Ltd. There are no other conflicts of interest declared.Funding StatementThis work was supported by the New Zealand Health Research Council, The Royal Australasian College of Surgeons John Mitchell Crouch Fellowship (GOG), and the Auckland Medical Research Foundation Douglas Goodfellow Medical Research Fellowship (THHW).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Auckland Health Research Ethics Committee (granted. Reference AH1125)I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors